The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

April 30, 1999

Study Completion Date

October 31, 1999

Conditions
Chronic Low Back Pain
Interventions
DRUG

Buprenorphine transdermal delivery system

Trial Locations (22)

22206

The Arthritis Clinic of Northern Virginia, Arlington

27262

Cornerstone Research Care, High Point

32119

Coastal Medical Research, South Daytona Beach

32605

Gainesville Clinical Research Center, Gainesville

32720

University Clinical Research, DeLand

33173

Miami Research Associates, Miami

33331

Private Practice, Weston

33409

Palm Beach Research Center, West Palm Beach

34239

Sarasota Arthritis Center, Sarasota

35801

Rheumatology Associates of North Alabama, Huntsville

39216

Arthritis & Osteoporosis Treatment & Research Center, Jackson

41017

Riverhills Healthcare, Crestview Hills

45219

Consultants for Clinical Research, Cincinnati

47807

Pain Management & Rehabilitation, Terre Haute

53226

Private Practice, Wauwatosa

64114

Center for Pharmaceutical Research, Kansas City

66209

Mid-America Rheumatology Consultants, Overland Park

78758

Center for Clinical Research, Austin

85023

Arizona Research Center, Phoenix

89128

PrecisionMed, Inc., Las Vegas

98026

Evergreen Clinical Research, Edmonds

06708

Arthritis Center of Connecticut, Waterbury

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY